1 / 9

Ditropan-associated Esotropia

Ditropan-associated Esotropia. Dr. Elaine Wong Dr. Lionel Kowal Ocular motility clinic, RVEEH CERA, Uni Melb, RVEEH. Ditropan-associated ET. 5 yo girl PMHx Hypothyroidism – on oroxine Enuresis HOPC Recent onset intermittent ET Closing L eye when drawing or reading

red
Download Presentation

Ditropan-associated Esotropia

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Ditropan-associated Esotropia Dr. Elaine Wong Dr. Lionel Kowal Ocular motility clinic, RVEEH CERA, Uni Melb, RVEEH

  2. Ditropan-associated ET • 5 yo girl PMHx • Hypothyroidism – on oroxine • Enuresis HOPC • Recent onset intermittent ET • Closing L eye when drawing or reading • Recently started on Ditropan (Oxybutynin) for enuresis

  3. Examination @ presentation • VAR 6/8 VAL 6/8 • Near VAR 6/9 VAL 6/8 • Stereopsis: Titmus fly 100” • CT: D) RET 15Δ N) RET’ 35Δ • OM: normal • Polarised 4 dot test: R suppression • Cycloplegic refraction: • R: +3.25; L + 2.75

  4. Ditropan-associated ET • After cessation of Oxybutynin • VAR 6/8 VAL 6/8 • Near VAR 6/6 VAL6/8 • CT: D) orthophoria • N) orthophoria • ELAINE : CHECK THE DATA ON THIS SLIDE PLS • Polarised 4 dot test: Fusion • Stereopsis: Titmus fly 100”

  5. Discussion - Oxybutynin • Muscarinic receptor antagonist often used for overactive bladder • COMMONLY PRESCRIBED • Anticholinergic systemic SE • Ocular effects • Ciliary ganglion – accomodation • Pterygopalatine ganglion – lacrimation

  6. Ocular side-effects of tolterodine and oxybutynin, a single-blind prospective randomized trial Altan-Yaycioglu et al. Br J Clin Pharmacol 95:5, 588-592 • 52 patients, 104 eyes • Randomised into • Tolterodine 2mg bd – 28 pts • Oxybutynin 5 mg tds – 24 pts • All examined by ophthalmologists • Schirmer’s • Accomodative amplitude • Pupillary diameter PD

  7. Discussion Tolterodine Oxybutynin Accom amp (DS) 2.06 to 1.65 2.18 to 1.80 (p = 0.07) (p = 0.003) Schirmer’s (mm) 12.82 to 12.32 12.21 to 14.83 (p = 0.698) (p = 0.342) PD bright (mm) 1.94 to 2.02 2.07 to 2.08 (p = 0.174) ( p = 0.953)

  8. Discussion • In this case Oxybutynin • Impairs accommodation • Pre-existing moderate uncorrected + • To accommodate sufficiently to see, the pt converges, and the CA/C ratio then generates accommodation • hence ESOTROPIA!!! • ? Is Tolterodine (Detrusitol) safer

  9. Ditropan • Frequently prescribed • Has never been described as cause of ET! • Likely to cause accommodation and  convergence • Dit + hyperopia likely to cause ET • Almost certainly underrecognised

More Related